Osprey Medical appoints Mr Neville Mitchell to its Board of Directors

Posted: 2012-07-03 in Press Releases

Download PDF

Osprey Medical appoints Mr Neville Mitchell to its Board of Directors and hires Vice President of Operations and Quality.

Minnesota, United States and Sydney, Australia - July 3, 2012 - Osprey Medical (ASX-OSP) today announced that Mr Neville Mitchell has joined the Company’s Board of Directors. Mr Mitchell is currently the Chief Financial Officer and Company Secretary at Cochlear Limited, one of Australia's largest medical device companies which is focused on solutions for the hearing impaired. 

Mr Mitchell will serve as an Independent Director as well as Chair of Osprey Medical's Audit Committee.  John Erb, Chairman of the Board of Osprey Medical said: "We are pleased to welcome Neville to our Board; his strong financial acumen and rich experience in building a successful Australian medical device company will strengthen our Board."

Mr Mitchell was part of the team that successfully listed Cochlear on the ASX in 1995 and part of the Executive team that has driven the Company's growth and development since then.  He currently has responsibility for Cochlear's accounting, corporate finance, treasury, audit, investor relations, secretarial, and corporate legal functions.  Prior to Cochlear, Mr Mitchell was a senior manager with KPMG in Johannesburg, South Africa.

Mr Mitchell commented: "I am pleased to be joining Osprey Medical at this early juncture following its recent listing on the ASX. The CINCOR technology offers an advanced level of kidney protection for at-risk patients undergoing a stenting procedure, and I look forward to working with the Board and Management Team to continue to drive corporate shareholder value."

Osprey Medical also announced that Vic Fabano has joined the Company's Executive Management Team as Vice President of Operations and Quality.  Mr Fabano has more than 20 years' experience in the medical device industry with the last 15 years serving as an Executive in charge of manufacturing, operations, quality, and product development. Prior to joining Osprey Medical, Mr Fabano served as Vice President of Operations and Quality for Anulex Technologies from 2008-2012 a venture capital backed spinal device company.  During this appointment Mr Fabano established an FDA compliant scalable manufacturing infrastructure focused on cost, quality and delivery.

Mike McCormick, President and CEO of Osprey Medical, said: “Mr Fabano has the skills, abilities and previous experience to greatly contribute to Osprey Medical’s positive progress.  As we ramp up our clinical and commercial activities in the near future, I am confident Mr Fabano’s seasoned leadership will drive success in our Operation and Quality functions.